GlassScriptPhysician profile
Debra A Shim
NPI 1407907413
$5,598.56
in general payments reported to CMS, 2019-2025
19 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $223 · 2021: $248 · 2022: $694 · 2023: $512 · 2024: $1,385 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,739 · Gift: $200 · Entertainment: $54.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,739.13 |
| Gift | $200.00 |
| Entertainment | $54.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,198.48 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,091.41 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $630.20 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $444.54 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $426.14 | 2022-2025 | Precision7, Dailies Total1, Total30 |
| Tarsus Pharmaceuticals, INC. | $310.59 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $250.48 | 2019-2023 | Tearcare System |
| Glaukos Corporation | $202.54 | 2024-2025 | Idose, Idosetr |
| Visionary Optics LLC | $200.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $143.70 | 2019-2020 | |
| Astellas Pharma US INC | $133.32 | 2024 | Izervay |
| Rxsight INC | $125.00 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Horizon Therapeutics Plc | $124.97 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $124.38 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $63.40 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $54.29 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Optovue, INC. | $31.25 | 2020 | |
| Dompe US, INC. | $24.47 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Shim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.